Myers (MYE) Q1 2026 Earnings Call Transcript

Myers Industries delivered a strong Q1 with adjusted EPS up 57.1% to $0.44, adjusted EBITDA up 27%, and adjusted EBITDA margin expanding 420 bps to 21.3%. Net sales rose 1.8% year over year, or 5% excluding exited low-margin products, while free cash flow increased to $23.9 million and net debt fell by $18.3 million. Management reaffirmed 2026 guidance, but flagged near-term gross margin pressure from rising HD polyethylene/resin costs even as infrastructure demand and MegaDeck orders remain strong.

Analysis

The core setup is a classic margin-recovery story with a cleaner balance sheet, but the more interesting takeaway is that Myers is narrowing its economic exposure faster than revenue is shrinking. Exiting low-margin lines and re-optimizing plant footprint should mechanically lift incremental margins even if top-line growth stays modest, which means the equity can rerate on earnings power rather than absolute sales growth. That makes FY26 less about demand normalization and more about whether management can preserve pricing power through the resin spike while keeping the new mix intact.

The second-order winner is any business line tied to infrastructure ground protection and event-driven temporary surface demand, because capacity is being added with relatively little capital and the company appears to be reallocating existing manufacturing rather than chasing greenfield expansion. The implied bottleneck is no longer customer demand; it is execution risk in plant specialization and timing of the Orlando capacity ramp. If they miss the ramp or resin inflation lasts longer than a quarter or two, the market will question whether the second-half margin rebound is real or just deferred.

The contrarian view is that the market may be underestimating how much of the current outperformance is already “pulled forward” by favorable mix and working-capital timing. A 2.2x leverage ratio is acceptable, but it also limits optionality if commodity inflation persists and demand in vehicle or food-related end markets stays soft. The upside case is strong if infrastructure and defense remain above-plan into 2H; the downside is that this becomes a low-quality earnings beat followed by margin giveback.

From a trading standpoint, this looks more attractive as a tactical long than a structural compounder: the next 1-2 quarters should benefit from earnings revisions, but the base case still depends on price pass-through catching up to resin. The better risk/reward is to own it into the margin-recovery window and fade it if the stock starts to discount a clean second-half reacceleration before evidence appears. Near-term catalysts are order commentary, Q2 gross margin pressure, and any update on the MTS sale timing.

Key Decisions for Investors

• Long MYE for 1-2 quarters into the expected second-half margin rebound; target a re-rating on revised FY26 EPS if resin costs stabilize and pricing catches up. Risk: Q2 gross margin compression could force multiple contraction first.
• Buy MYE call spreads into the next earnings print or any pullback tied to resin headlines. Best setup is a 3-6 month spread, financed by selling upside once the market prices in the first leg of margin recovery.
• Pair trade: long MYE / short a higher-quality industrial cyclicals basket on the thesis that MYE has more near-term EPS delta from mix, divestiture, and cost actions. Exit if management signals the Orlando capacity ramp slips beyond Q1 next year.
• Avoid adding on strength if the stock trades as if the MTS divestiture is immediately accretive; the cleaner story is real, but the timing risk around closing and integration of remaining businesses is not free.
• Set a stop-loss framework around any failure of Q2 margin guidance or evidence that pricing lag outlasts the second quarter; that would invalidate the trade’s main catalyst and likely compress the multiple.